Literature DB >> 32795496

Polypoidal Choroidal Vasculopathy: Consensus Nomenclature and Non-Indocyanine Green Angiograph Diagnostic Criteria from the Asia-Pacific Ocular Imaging Society PCV Workgroup.

Chui M Gemmy Cheung1, Timothy Y Y Lai2, Kelvin Teo3, Paisan Ruamviboonsuk4, Shih-Jen Chen5, Judy E Kim6, Fumi Gomi7, Adrian H Koh8, Gregg Kokame9, Janice Marie Jordan-Yu10, Federico Corvi11, Alessandro Invernizzi12, Yuichiro Ogura13, Colin Tan14, Paul Mitchell15, Vishali Gupta16, Jay Chhablani17, Usha Chakravarthy18, Srinivas R Sadda19, Tien Y Wong3, Giovanni Staurenghi11, Won Ki Lee20.   

Abstract

PURPOSE: To develop consensus terminology in the setting of polypoidal choroidal vasculopathy (PCV) and to develop and validate a set of diagnostic criteria not requiring indocyanine green angiography (ICGA) for differentiating PCV from typical neovascular age-related macular degeneration (nAMD) based on a combination of OCT and color fundus photography findings.
DESIGN: Evaluation of diagnostic test results. PARTICIPANTS: Panel of retina specialists.
METHODS: As part of the Asia-Pacific Ocular Imaging Society, an international group of experts surveyed and discussed the published literature regarding the current nomenclature and lesion components for PCV, and proposed an updated consensus nomenclature that reflects our latest understanding based on imaging and histologic reports. The workgroup evaluated a set of diagnostic features based on OCT images and color fundus photographs for PCV that may distinguish it from typical nAMD and assessed the performance of individual and combinations of these non-ICGA features, aiming to propose a new set of diagnostic criteria that does not require the use of ICGA. The final recommendation was validated in 80 eyes from 2 additional cohorts. MAIN OUTCOME MEASURES: Consensus nomenclature system for PCV lesion components and non-ICGA-based criteria to differentiate PCV from typical nAMD.
RESULTS: The workgroup recommended the terms polypoidal lesion and branching neovascular network for the 2 key lesion components in PCV. For the diagnosis of PCV, the combination of 3 OCT-based major criteria (sub-retinal pigment epithelium [RPE] ring-like lesion, en face OCT complex RPE elevation, and sharp-peaked PED) achieved an area under the receiver operating characteristic curve of 0.90. Validation of this new scheme in a separate subset 80 eyes achieved an accuracy of 82%.
CONCLUSIONS: We propose updated terminology for PCV lesion components that better reflects the nature of these lesions and is based on international consensus. A set of practical diagnostic criteria applied easily to spectral-domain OCT results can be used for diagnosing PCV with high accuracy in clinical settings in which ICGA is not performed routinely.
Copyright © 2020 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Accuracy; Aneurysmal; Angiography; Diagnosis; Differentiation; Imaging; Neovascularization; Noninvasive; OCT; Polypoidal choroidal vasculopathy; Screening; Sensitivity and specificity

Mesh:

Substances:

Year:  2020        PMID: 32795496     DOI: 10.1016/j.ophtha.2020.08.006

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  25 in total

1.  Quantitative analysis of branching neovascular networks in polypoidal choroidal vasculopathy by optical coherence tomography angiography after photodynamic therapy and anti-vascular endothelial growth factor combination therapy.

Authors:  Wen-Yi Wang; Chang-Hao Yang; Ta-Ching Chen; Yi-Ting Hsieh; Tzyy-Chang Ho; Chung-May Yang; Fang-Yu Liu; Tso-Ting Lai
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-02-08       Impact factor: 3.117

2.  Comparison of 3-year outcomes of photodynamic therapy combined with intravitreal ranibizumab or aflibercept for polypoidal choroidal vasculopathy in a European cohort.

Authors:  Siyin Liu; Ramandeep Chhabra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-06-09       Impact factor: 3.535

3.  Case series: pachychoroid pigment epitheliopathy transformed to polypoidal choroidal vasculopathy after long-term follow-up.

Authors:  Jiyang Tang; Xinyao Han; Ran Tang; Mengyang Li; Zongyi Wang; Mingwei Zhao; Jinfeng Qu
Journal:  BMC Ophthalmol       Date:  2022-06-21       Impact factor: 2.086

4.  Pachychoroid neovasculopathy can mimic wet type age-related macular degeneration.

Authors:  Mohsen Farvardin; Abdulrahim Amini; Younes Azizpourfard; Masoud Yasemi; Zahra Mahdizad; Mohammadkarim Johari
Journal:  Int J Retina Vitreous       Date:  2022-10-23

5.  Infographic: non-ICGA imaging for polypoidal choroidal vasculopathy (PCV) - Asia-Pacific Ocular Imaging Society PCV workgroup report 1 & 2.

Authors:  Christopher Ziyu Sun; Shaun Sebastian Khung Peng Sim; Chinmayi Himanshuroy Vyas; Pooi Wah Lott; Rubamalar Gunatheesan; Kelvin Yi Chong Teo; Chui Ming Gemmy Cheung
Journal:  Eye (Lond)       Date:  2022-01-20       Impact factor: 4.456

6.  Distinguishing retinal angiomatous proliferation from polypoidal choroidal vasculopathy with a deep neural network based on optical coherence tomography.

Authors:  Daniel Duck-Jin Hwang; Seong Choi; Junseo Ko; Jeewoo Yoon; Ji In Park; Joon Seo Hwang; Jeong Mo Han; Hak Jun Lee; Joonhong Sohn; Kyu Hyung Park; Jinyoung Han
Journal:  Sci Rep       Date:  2021-04-29       Impact factor: 4.379

7.  Associations of ARMS2 and CFH Gene Polymorphisms with Neovascular Age-Related Macular Degeneration.

Authors:  Supanji Supanji; Dewi Fathin Romdhoniyyah; Muhammad Bayu Sasongko; Angela Nurini Agni; Firman Setya Wardhana; Tri Wahyu Widayanti; Muhammad Eko Prayogo; Ayudha Bahana Ilham Perdamaian; Aninditta Dianratri; Masashi Kawaichi; Chio Oka
Journal:  Clin Ophthalmol       Date:  2021-03-11

8.  Choroidal Changes in Eyes With Polypoidal Choroidal Vasculopathy After Anti-VEGF Therapy Imaged With Swept-Source OCT Angiography.

Authors:  Mengxi Shen; Hao Zhou; Kiyoung Kim; Qiyu Bo; Jie Lu; Rita Laiginhas; Xiaoshuang Jiang; Quan Yan; Prashanth Iyer; Omer Trivizki; Yingying Shi; Luis de Sisternes; Mary K Durbin; William Feuer; Giovanni Gregori; Ruikang K Wang; Xiaodong Sun; Fenghua Wang; Seung-Young Yu; Philip J Rosenfeld
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-12-01       Impact factor: 4.799

9.  Multicentre, randomised clinical trial comparing intravitreal aflibercept monotherapy versus aflibercept combined with reduced-fluence photodynamic therapy (RF-PDT) for the treatment of polypoidal choroidal vasculopathy.

Authors:  Chinmayi Himanshuroy Vyas; Chui Ming Gemmy Cheung; Colin Tan; Caroline Chee; Kelly Wong; Janice Marie N Jordan-Yu; Tien Yin Wong; Anna Tan; Beau Fenner; Shaun Sim; Kelvin Yi Chong Teo
Journal:  BMJ Open       Date:  2021-07-15       Impact factor: 2.692

Review 10.  Applications of Multimodal Imaging in Central Serous Chorioretinopathy Evaluation.

Authors:  Mary Ho; Gabriel Li; Andrew Mak; Danny Ng; Lawrence Iu; Frank Lai
Journal:  J Ophthalmol       Date:  2021-07-24       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.